Communiqués Invion Limited

Actions

IVX

AU000000IVX4

Recherche biotechnologique et médicale

Marché Fermé - Australian S.E. 06:18:59 05/10/2026			Varia. 5j.	Varia. 1 janv.
0,0420 ^AUD	+10,53%		+10,53%	-54,84%

26/08	Invion Limited publie ses résultats pour l'exercice clos le 30 juin 2026	CI
26/08	Invion Limited : l'auditeur exprime des doutes sur la continuité de l'exploitation	CI

Communiqués

18/09/24	Invion Limited (ASX:IVX) Prostate Cancer Trial Results	AQ
21/07/22	Invion : Activities Report and Appendix 4C	PU
20/06/22	Invion : Notification regarding unquoted securities - IVX	PU
20/04/22	Invion : Activities Report and Appendix 4C	PU
21/03/22	Invion : Notification regarding unquoted securities - IVX	PU
25/02/22	Invion : Notice of General Meeting/Proxy Form	PU
03/02/22	Invion : Investor Presentation	PU
01/02/22	Invion : Application for quotation of securities - IVX	PU
20/01/22	Invion : Activities Report and Appendix 4C	PU
12/12/21	Invion : Application for quotation of securities - IVX	PU
07/12/21	Invion : Notification regarding unquoted securities - IVX	PU
25/11/21	Invion : Proposed issue of securities - IVX	PU
23/11/21	Invion : Cancel - Proposed issue of securities - IVX	PU
22/11/21	Invion : Proposed issue of securities - IVX	PU
22/11/21	Invion : Prospectus	PU
22/11/21	Invion : Share Purchase Plan Offer Booklet & Application Form	PU
21/11/21	Invion : Application for quotation of securities - IVX	PU
16/11/21	Invion : Proposed issue of securities - IVX	PU
29/01/19	Invion : selects Guilin Xingda to manufacture light-therapy medical equipment	PU
07/11/18	Invion : Collaborates to Develop Powerful Skin Cancer Gel	PU
27/09/18	Invion : spin-off Chronic Airway Therapeutics selects leading CRO for the future development of nadolol	PU
07/09/18	Invion : Demerger of respiratory assets – clarification on eligible shareholders	PU
05/07/18	Invion : Photosoft efficiently destroys ovarian cancer cells in vitro	PU
14/09/17	Invion : announces strategic transaction	PU
28/04/17	Invion : appendix 4C – March 2017 quarter	PU